Mei et al. exploited CRISPR-dead Cas9 (dCas9) system to induce Yamanaka’s factors (OCT4, SOX2, KLF4, and MYC) in a luminal breast cancer cell line with an innovative multiplexing system. The gene discussed is SOX2; the disease is breast carcinoma.